Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5

Hodder, AN; Drew, DR; Epa, VC; Delorenzi, M; Bourgon, R; Miller, SK; Moritz, RL; Frecklington, DF; Simpson, RJ; Speed, TP; Pike, RN; Crabb, BS

Author(s): Hodder, AN; Drew, DR; Epa, VC; Delorenzi, M; Bourgon, R; Miller, SK; Moritz, RL; Frecklington, DF; Simpson, RJ; Speed, TP; Pike, RN; Crabb, BS;
Details: Publication Year 2003-11-28,Volume 278,Issue #48,Page 48169-48177
Journal Title: JOURNAL OF BIOLOGICAL CHEMISTRY
Publication Type: Journal Article
Abstract: Serine repeat antigen 5 (SERA5) is an abundant antigen of the human malaria parasite Plasmodium falciparum and is the most strongly expressed member of the nine-gene SERA family. It appears to be essential for the maintenance of the erythrocytic cycle, unlike a number of other members of this family, and has been implicated in parasite egress and/or erythrocyte invasion. All SERA proteins possess a central domain that has homology to papain except in the case of SERA5 ( and some other SERAs), where the active site cysteine has been replaced with a serine. To investigate if this domain retains catalytic activity, we expressed, purified, and refolded a recombinant form of the SERA5 enzyme domain. This protein possessed chymotrypsin-like proteolytic activity as it processed substrates downstream of aromatic residues, and its activity was reversed by the serine protease inhibitor 3,4-diisocoumarin. Although all Plasmodium SERA enzyme domain sequences share considerable homology, phylogenetic studies revealed two distinct clusters across the genus, separated according to whether they possess an active site serine or cysteine. All Plasmodia appear to have at least one member of each group. Consistent with separate biological roles for members of these two clusters, molecular modeling studies revealed that SERA5 and SERA6 enzyme domains have dramatically different surface properties, although both have a characteristic papain-like fold, catalytic cleft, and an appropriately positioned catalytic triad. This study provides impetus for the examination of SERA5 as a target for antimalarial drug design.
Publisher: AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
Keywords: APICAL MEMBRANE ANTIGEN-1; HUMAN MALARIA PARASITE; BLOOD STAGE ANTIGEN; GENOME SEQUENCE; SERINE-STRETCH; PROCATHEPSIN B; LOCALIZATION; RECOGNITION; INHIBITION; MEROZOITES
Publisher's Version: https://doi.org/10.1074/jbc.M306755200
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2003-11-28 12:00:00